Scientists create smart cells that administer automatic treatments from inside the human body, reacting within seconds to ...

The Cancer Immunotherapy market, valued at USD 220.94 billion in 2024, is expected to register robust revenue CAGR of 13.6%.

Researchers demonstrated that systemic factors from young mice can rejuvenate the aging retina by alleviating cellular senescence and restoring function.

In July 2025, Inovio Pharmaceuticals conducted a Phase 1/2 trial to evaluate safety, immunogenicity and preliminary efficacy of INO-5401 and INO-9012 in combination with cemiplimab (REGN2810), with ...

New data shows Telomir-1 fully reverses STAT1 gene silencing by DNA methylation - a key immune regulator suppressed in cancer - delivering stronger epigenetic effects than Paclitaxel or Rapamycin in ...

BOSTON: Elenagen ™, a novel DNA plasmid therapy that previously demonstrated high clinical benefit and low toxicity in cancer patients, has now shown ...

Understanding the gut-brain axis is key to addressing eating disorders. This study highlights microbiota's influence and ...

Prenatal stress in mothers can leave a lasting imprint on their offspring, predisposing them to depression-like behaviors.

Viewed this way, “Mind-Body medicine” is the tail wagging the dog, to put it mildly.

Cullinan's innovative approach and Zipalertinib's potential approval in 2026 position it as a promising biotech investment.

N6-methyladenosine (m6A) serves as a critical RNA modification, dynamically governing RNA metabolism through its influence on RNA stability, splicing, ...

In a regulatory filing, Telomir Pharmaceuticals (TELO) reported new preclinical results evaluating the effects of its lead candidate, Telomir-1, ...